Acadian Asset Management LLC Pacira Bio Sciences, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$30.8 - $52.47 $22,545 - $38,408	-732 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$28.4 - $50.7 $20,788 - $37,112	732 New	732 $25,000
Q4 2019 Feb 06, 2020	SELL	$36.31 - $46.83 $9,041 - $11,660	-249 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$35.66 - $44.99 $8,879 - $11,202	249 New	249 $9,000
Q2 2019 Aug 08, 2019	SELL	$36.57 - $47.97 $1.92 Million - $2.52 Million	-52,598 Closed	0 $0

Q1 2019 May 09, 2019	SELL	$36.47 - $42.17 $202,226 - $233,832	-5,545 Reduced 9.54%	52,598 $2 Million
Q4 2018 Feb 07, 2019	SELL	$41.31 - $52.16 $9,997 - $12,622	-242 Reduced 0.41%	58,143 $2.5 Million
Q3 2018 Oct 30, 2018	BUY	$32.85 - $52.0 $1.92 Million - $3.04 Million	58,385 New	58,385 $2.87 Million

291

48.5M

156K

623K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $918M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.